Literature DB >> 27784586

Penile Prosthesis Implantation in Acute and Chronic Priapism.

Giulio Garaffa1, David J Ralph2.   

Abstract

AIM: To review the current literature regarding penile prosthesis implantation in acute and chronic priapism.
METHODS: A nonstructured Pubmed base search using the terms ischemic priapism, penile prosthesis, and refractory erectile dysfunction has been carried out. MAIN OUTCOME MEASURES: Surgical outcome and patient satisfaction following penile prosthesis implantation are reported.
RESULTS: Implantation of a penile prosthesis in acute and chronic ischemic priapism is associated with increased complication rates, when compared with virgin implants. Implantation in acute priapism allows the painful priapic episode to settle and to preserve penile length, while implantation in chronic priapism is technically much more challenging and often requires the use of downsized shorter cylinders.
CONCLUSION: Implantation of a penile prosthesis in acute refractory ischemic priapism should be the solution of choice, as the dilatation is easier and allows the preservation of penile length, which is one of the main factors influencing postoperative patient's satisfaction in prosthetic surgery. Garaffa G and Ralph D. Penile prosthesis implantation in acute and chronic priapism. Sex Med Rev 2013;1:76-82.
Copyright © 2013 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Erectile Dysfunction; Fibrosis; Ischemic Priapism; Penile Prosthesis

Year:  2015        PMID: 27784586     DOI: 10.1002/smrj.10

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  2 in total

Review 1.  Contemporary best practice in the evaluation and management of stuttering priapism.

Authors:  Georgios Kousournas; Asif Muneer; David Ralph; Evangelos Zacharakis
Journal:  Ther Adv Urol       Date:  2017-07-04

Review 2.  Surgical tips in difficult penile prosthetic surgery: a narrative review.

Authors:  Nicolò Schifano; Paolo Capogrosso; Onur Omer Cakir; Federico Dehò; Giulio Garaffa
Journal:  Int J Impot Res       Date:  2022-10-19       Impact factor: 2.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.